• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?

作者信息

Lau Harry Cheuk-Hay, Ng Siew C, Yu Jun

机构信息

Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.

Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, Center for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China; Microbiota I-Center (MagIC), Hong Kong SAR, China.

出版信息

Gastroenterology. 2022 Jan;162(1):9-16. doi: 10.1053/j.gastro.2021.09.009. Epub 2021 Sep 8.

DOI:10.1053/j.gastro.2021.09.009
PMID:34508775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8425294/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e4/8425294/5f8c4276a33c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e4/8425294/5f8c4276a33c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e4/8425294/5f8c4276a33c/gr1_lrg.jpg

相似文献

1
Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?针对2019冠状病毒病的肠道微生物群：炒作还是希望？
Gastroenterology. 2022 Jan;162(1):9-16. doi: 10.1053/j.gastro.2021.09.009. Epub 2021 Sep 8.
2
Crosstalk between COVID-19 and the gut-brain axis: a gut feeling.新冠病毒与肠脑轴的相互作用：一种直觉。
Postgrad Med J. 2024 Jul 18;100(1186):539-554. doi: 10.1093/postmj/qgae030.
3
Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut Microbiota Dysbiosis: Study Protocol for a Randomized Controlled Trial.经洗涤的微生物群移植治疗轻至重度 COVID-19 患者和疑似肠道微生物群失调的疗效和安全性：一项随机对照试验的研究方案。
Curr Med Sci. 2021 Dec;41(6):1087-1095. doi: 10.1007/s11596-021-2475-2. Epub 2021 Nov 30.
4
Microbiota Modulation of the Gut-Lung Axis in COVID-19.肠道菌群对 COVID-19 的肺肠轴的调节。
Front Immunol. 2021 Feb 24;12:635471. doi: 10.3389/fimmu.2021.635471. eCollection 2021.
5
Role of Probiotics in the Management of COVID-19: A Computational Perspective.益生菌在 COVID-19 管理中的作用：计算视角。
Nutrients. 2022 Jan 10;14(2):274. doi: 10.3390/nu14020274.
6
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.2019 年冠状病毒病中肠道微生物组的改变及其治疗潜力。
World J Gastroenterol. 2022 Dec 21;28(47):6689-6701. doi: 10.3748/wjg.v28.i47.6689.
7
From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.从肠道菌群在肺肠轴中的作用到 SARS-CoV-2 的发病机制。
Mediators Inflamm. 2021 Apr 16;2021:6611222. doi: 10.1155/2021/6611222. eCollection 2021.
8
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.肠道细菌失调和不稳定与 COVID-19 并发症和死亡率的发生有关。
Gut Microbes. 2022 Jan-Dec;14(1):2031840. doi: 10.1080/19490976.2022.2031840.
9
The impact of probiotics on interactions within the microbiota-gut-lung triad in COVID-19.益生菌对新型冠状病毒肺炎中微生物群-肠-肺三联体内部相互作用的影响。
Int J Food Sci Nutr. 2021 Jun;72(4):577-578. doi: 10.1080/09637486.2020.1850651. Epub 2021 Jan 2.
10
Probiotics and Coronavirus disease 2019: think about the link.益生菌与 2019 年冠状病毒病：关注二者的关联。
Br J Nutr. 2021 Nov 28;126(10):1564-1570. doi: 10.1017/S000711452000361X. Epub 2020 Sep 14.

引用本文的文献

1
Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome.靶向发现肠道微生物组重塑化合物，用于治疗全身炎症反应综合征。
mSystems. 2024 Oct 22;9(10):e0078824. doi: 10.1128/msystems.00788-24. Epub 2024 Sep 5.
2
A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.肌痛性脑脊髓炎/慢性疲劳综合征中肠道微生物组紊乱和微生物制剂的叙述性综述：对长新冠的影响。
Nutrients. 2024 May 21;16(11):1545. doi: 10.3390/nu16111545.
3
Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions.

本文引用的文献

1
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.美沙拉嗪可降低小鼠肠道ACE2表达，但不改变小鼠感染SARS-CoV-2的情况或疾病严重程度。
Inflamm Bowel Dis. 2022 Feb 1;28(2):318-321. doi: 10.1093/ibd/izab274.
2
COVID vaccine boosters: the most important questions.新冠疫苗加强针：最重要的问题。
Nature. 2021 Aug;596(7871):178-180. doi: 10.1038/d41586-021-02158-6.
3
Rapid resolution of COVID-19 after faecal microbiota transplantation.粪便微生物群移植后新冠病毒病的快速缓解
新型冠状病毒肺炎患者微生物群的改变：对治疗干预的启示
MedComm (2020). 2024 Mar 15;5(4):e513. doi: 10.1002/mco2.513. eCollection 2024 Apr.
4
Impact of SARS-CoV2 infection on gut microbiota dysbiosis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对肠道微生物群失调的影响。
Microbiome Res Rep. 2023 Dec 6;3(1):7. doi: 10.20517/mrr.2023.48. eCollection 2024.
5
Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19.新冠后遗症中的微生物组与肠道病理生理学
Genes Dis. 2023 Jun 19;11(3). doi: 10.1016/j.gendis.2023.03.034.
6
Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants.功能性食品：一种恢复受 SARS-CoV-2 变异影响的肠道微生物多样性的有前途策略。
Nutrients. 2023 Jun 5;15(11):2631. doi: 10.3390/nu15112631.
7
Gut microbiota and synbiotic foods: Unveiling the relationship in COVID-19 perspective.肠道微生物群与合生元食品：从新冠肺炎角度揭示两者关系。
Food Sci Nutr. 2023 Jan 11;11(3):1166-1177. doi: 10.1002/fsn3.3162. eCollection 2023 Mar.
8
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.持续的 SARS-CoV-2 感染、EBV、HHV-6 及其他因素可能导致长新冠中的炎症和自身免疫。
Viruses. 2023 Jan 31;15(2):400. doi: 10.3390/v15020400.
9
Ongoing Treatment with a Spore-Based Probiotic Containing Five Strains of Improves Outcomes of Mild COVID-19.含有五株 的孢子益生菌持续治疗可改善轻度 COVID-19 的结局。
Nutrients. 2023 Jan 17;15(3):488. doi: 10.3390/nu15030488.
10
Dynamic changes in host immune system and gut microbiota are associated with the production of SARS-CoV-2 antibodies.宿主免疫系统和肠道微生物群的动态变化与新冠病毒抗体的产生有关。
Gut. 2023 Oct;72(10):1996-1999. doi: 10.1136/gutjnl-2022-327561. Epub 2022 Oct 7.
Gut. 2022 Jan;71(1):230-232. doi: 10.1136/gutjnl-2021-325010. Epub 2021 Jul 6.
4
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19.新冠病毒感染患者口腔和肠道微生物组及脂质组的变化。
Gut. 2021 Jul;70(7):1253-1265. doi: 10.1136/gutjnl-2020-323826. Epub 2021 Mar 31.
5
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.肠道宿主对 SARS-CoV-2 感染的反应和有胃肠道症状的 COVID-19 患者的结局。
Gastroenterology. 2021 Jun;160(7):2435-2450.e34. doi: 10.1053/j.gastro.2021.02.056. Epub 2021 Mar 4.
6
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.肠道微生物群落组成反映了 COVID-19 患者的疾病严重程度和功能失调的免疫反应。
Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.
7
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
8
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.血管紧张素转化酶 2 在调节肠道微生物群、肠道炎症和冠状病毒感染中的作用。
Gastroenterology. 2021 Jan;160(1):39-46. doi: 10.1053/j.gastro.2020.07.067. Epub 2020 Oct 30.
9
Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.2019冠状病毒病（COVID-19）住院患者的经验性抗菌治疗与社区获得性细菌合并感染：一项多中心队列研究
Clin Infect Dis. 2021 May 18;72(10):e533-e541. doi: 10.1093/cid/ciaa1239.
10
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.描绘 COVID-19 患者中 SARS-CoV-2 粪便病毒活性与肠道微生物群落组成的关系。
Gut. 2021 Feb;70(2):276-284. doi: 10.1136/gutjnl-2020-322294. Epub 2020 Jul 20.